Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab

被引：0
|
作者：
Remolina-Bonilla, Yuly A. [1 ]
Jimenez-Franco, Brenda [1 ]
Lam, Elaine T. [2 ]
Bourlon, Maria T. [3 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[2] Univ Colorado, Dept Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO USA
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Hematol & Med Oncol Dept, Mexico City, DF, Mexico
来源：
ONCOLOGY-NEW YORK | 2020年 / 34卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：171 / 174
页数：4
相关论文
共 50 条
  • [21] Correlation between immune-related adverse events and outcomes in nivolumab/ipilimumab combination therapy for metastatic melanoma
    Rauwerdink, Daan
    Frederick, Dennie T.
    Sharova, Tatyana
    Marie, Genevieve
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [22] Immune-related adverse events and prognosis in patients with upper gastrointestinal cancer treated with nivolumab
    Hara, Yoshihiro
    Baba, Yoshifumi
    Toihata, Tasuku
    Harada, Kazuto
    Ogawa, Katsuhiro
    Iwatsuki, Masaaki
    Iwagami, Shiro
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (06) : 2779 - 2788
  • [23] Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
    Weber, Jeffrey S.
    Kaehler, Katharina C.
    Hauschild, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2691 - 2697
  • [24] Efficacy of nivolumab in patients treated by corticosteroid due to immune-related adverse events.
    Higashiyama, Ryoko Inaba
    Horinouchi, Hidehito
    Sekine, Katsutoshi
    Matsumoto, Yuji
    Murakami, Shuji
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Yamamoto, Noboru
    Ohe, Yuichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [25] Characteristics of immune-related adverse events in patients with advanced esophageal cancer treated with nivolumab
    Nakada, Naokatsu
    Ando, Takayuki
    Motoo, Iori
    Kajiura, Shinya
    Fuchino, Mayo
    Sakumura, Miho
    Nanjo, Sohachi
    Mihara, Hiroshi
    Fujinami, Haruka
    Ogawa, Kohei
    Tsukada, Kenichiro
    Nakashima, Koji
    Hosokawa, Ayumu
    Yasuda, Ichiro
    ANNALS OF ONCOLOGY, 2021, 32 : S298 - S298
  • [26] Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab
    Suematsu, Hideaki
    Kano, Kazuki
    Yamada, Takanobu
    Hashimoto, Itaru
    Watanabe, Hayato
    Takahashi, Kosuke
    Watanabe, Mamoru
    Hayashi, Kei
    Kaneta, Yoshihiro
    Furuta, Mitsuhiro
    Inokuchi, Yasuhiro
    Machida, Nozomu
    Aoyama, Toru
    Tamagawa, Hiroshi
    Yukawa, Norio
    Rino, Yasushi
    Masuda, Munetaka
    Ogata, Takashi
    Oshima, Takashi
    ANTICANCER RESEARCH, 2022, 42 (03) : 1535 - 1540
  • [27] A case of dual-mechanism hematologic immune-related adverse event in a patient with metastatic melanoma treated with combined nivolumab and ipilimumab
    Olson, Daniel
    Tjota, Melissa
    Rajagopal, Padma
    Venkataraman, Girish
    Luke, Jason
    Gajewski, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [28] Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab
    Yamauchi, Ichiro
    Yasoda, Akihiro
    Matsumoto, Shigemi
    Sakamori, Yuichi
    Kim, Young Hak
    Nomura, Motoo
    Otsuka, Atsushi
    Yamasaki, Toshinari
    Saito, Ryoichi
    Kitamura, Morimasa
    Kitawaki, Toshio
    Hishizawa, Masakatsu
    Kawaguchi-Sakita, Nobuko
    Fujii, Toshihito
    Taura, Daisuke
    Sone, Masakatsu
    Inagaki, Nobuya
    PLOS ONE, 2019, 14 (05):
  • [29] Late-onset nivolumab-mediated pneumonitis in a patient with melanoma and multiple immune-related adverse events
    Diamantopoulos, Panagiotis T.
    Gaggadi, Maria
    Kassi, Eva
    Benopoulou, Olga
    Anastasopoulou, Amalia
    Gogas, Helen
    MELANOMA RESEARCH, 2017, 27 (04) : 391 - 395
  • [30] Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study
    Nukaya, Takuhisa
    Takahara, Kiyoshi
    Yoshizawa, Atsuhiko
    Saruta, Masanobu
    Yano, Yusuke
    Ohno, Takaya
    Uchimoto, Taizo
    Fukuokaya, Wataru
    Adachi, Takahiro
    Yamazaki, Shogo
    Tokushige, Satoshi
    Nishimura, Kazuki
    Tsujino, Takuya
    Nakamori, Keita
    Yamamoto, Shutaro
    Iwatani, Kosuke
    Urabe, Fumihiko
    Mori, Keiichiro
    Yanagisawa, Takafumi
    Tsuduki, Shunsuke
    Hirasawa, Yosuke
    Hashimoto, Takeshi
    Komura, Kazumasa
    Inamoto, Teruo
    Miki, Jun
    Kimura, Takahiro
    Ohno, Yoshio
    Azuma, Haruhito
    Shiroki, Ryoichi
    CLINICAL GENITOURINARY CANCER, 2024, 22 (01) : 76 - 83
12345